Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies

Parisa Vaseghi,Laleh Habibi,Julie A. Neidich,Yang Cao,Neda Fattahi,Ramin Rashidi-Nezhad,Tayebeh Salehnezhad,Hossein Dalili,Fatemeh Rahimi Sharbaf,Mohammad Reza Zarkesh,Mahtash Malekian,Mahdieh Mokhberdezfuli,Amirhosein Mehrtash,Amin Ardeshirdavani,Roxana Kariminejad,Vafa Ghorbansabagh,Parvane Sadeghimoghadam,Amir Naddaf,Tahereh Esmaeilnia Shirvany,Ziba Mosayebi,Behrokh Sahebdel,Fatemeh Golshahi,Mahboobeh Shirazi,Shirin Shamel,Roksana Moeini,Abolfazl Heidari,Mohammad Ali Daneshmand,Reza Ghasemi,Seyed Mohammad Akrami,Ali Rashidi-Nezhad
DOI: https://doi.org/10.1038/s41431-024-01533-x
2024-01-27
European Journal of Human Genetics
Abstract:Understanding the underlying causes of congenital anomalies (CAs) can be a complex diagnostic journey. We aimed to assess the efficiency of exome sequencing (ES) and chromosomal microarray analysis (CMA) in patients with CAs among a population with a high fraction of consanguineous marriage. Depending on the patient's symptoms and family history, karyotype/Quantitative Fluorescence- Polymerase Chain Reaction (QF-PCR) ( n = 84), CMA ( n = 81), ES ( n = 79) or combined CMA and ES ( n = 24) were performed on 168 probands (66 prenatal and 102 postnatal) with CAs. Twelve (14.28%) probands were diagnosed by karyotype/QF-PCR and seven (8.64%) others were diagnosed by CMA. ES findings were conclusive in 39 (49.36%) families, and 61.90% of them were novel variants. Also, 64.28% of these variants were identified in genes that follow recessive inheritance in CAs. The diagnostic rate (DR) of ES was significantly higher than that of CMA in children from consanguineous families ( P = 0·0001). The highest DR by CMA was obtained in the non-consanguineous postnatal subgroup and by ES in the consanguineous prenatal subgroup. In a population that is highly consanguineous, our results suggest that ES may have a higher diagnostic yield than CMA and should be considered as the first-tier test in the evaluation of patients with congenital anomalies.
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?